Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG), covering 2020-07-10 to 2020-07-10. Get the full timeline:
Most recent: Clinical Trial Update: Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19. [Phase 2, Phase 3]